Uranium Royalty (UROY) Cash & Equivalents (2022 - 2025)

Uranium Royalty's Cash & Equivalents history spans 3 years, with the latest figure at $9.1 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents fell 41.59% year-over-year to $9.1 million; the TTM value through Apr 2025 reached $9.1 million, down 41.59%, while the annual FY2025 figure was $9.3 million, 40.6% down from the prior year.
  • Cash & Equivalents for Q2 2025 was $9.1 million at Uranium Royalty, down from $15.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $15.6 million in Q2 2024 and bottomed at $9.1 million in Q2 2025.
  • The 3-year median for Cash & Equivalents is $10.6 million (2023), against an average of $11.7 million.
  • The largest annual shift saw Cash & Equivalents surged 47.19% in 2024 before it plummeted 41.59% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $10.6 million in 2023, then surged by 47.19% to $15.6 million in 2024, then tumbled by 41.59% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for UROY's Cash & Equivalents are $9.1 million (Q2 2025), $15.6 million (Q2 2024), and $10.6 million (Q2 2023).